Sada Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-07-2024
- Paid Up Capital ₹ 1.00 K
as on 02-07-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.63 Cr
as on 02-07-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets 1134.41%
(FY 2023)
About Sada Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 1.00 K .
The company currently has active open charges totaling ₹10.63 Cr.
Shyam Reddy, Venkata Vemireddy, Jaya Goli, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233TG2007PTC054755
- Company No.
054755
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sada Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Reddy  | Director | 10-Jun-2023 | Current |
| Venkata Vemireddy | Director | 18-Sep-2019 | Current |
| Jaya Goli | Director | 21-Oct-2021 | Current |
| Sivaramakrishna Alla | Director | 10-Jul-2007 | Current |
Financial Performance and Corporate Structure Insights of Sada Pharma.
Sada Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sada Pharma?
In 2023, Sada Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vj Fine Chem Private LimitedActive 7 years 10 months
Venkata Vemireddy and Jaya Goli are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Sep 2022 | ₹10.63 Cr | Open |
How Many Employees Work at Sada Pharma?
Unlock and access historical data on people associated with Sada Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sada Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sada Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
